ANI Pharmaceuticals: Worthy Of A Position [Seeking Alpha]
ANI Pharmaceuticals, Inc. (ANIP)
Last ani pharmaceuticals, inc. earnings: 2/27 08:30 am
Check Earnings Report
US:NASDAQ Investor Relations:
anipharmaceuticals.com/investors_corporate_profile.php
Company Research
Source: Seeking Alpha
ANIP's increasing reliance on Cortrophin Gel, projected to reach 52% of FY26 revenue, is offset by patent protection and a complex formulation. The company's balance sheet remains solid, supporting ongoing investments in rare disease expansion and 10–15 annual generic launches. An updated analysis around ANI Pharmaceuticals follows in the paragraphs below. Looking for a helping hand in the market? Members of The Biotech Forum get exclusive ideas and guidance to navigate any climate. Learn More » Sergii Kolesnikov/iStock via Getty Images Shares of diversified drug concern ANI Pharmaceuticals Inc. ( ANIP are down by roughly a quarter since reaching an all-time high of $99.50 in Sept 2025, falling again after a stellar 4Q25 report and FY26 outlook. I last More on my IG service Live Chat on The Biotech Forum sees frequent discussion of specific covered call trades. To see what covered call trades I am currently executing along with a model portfolio of attractive biotech st
Show less
Read more
Impact Snapshot
Event Time:
ANIP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ANIP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ANIP alerts
High impacting ANI Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
ANIP
News
- ANI Pharmaceuticals 2026 Watchlist: Gout Sales Force and Rare Disease [Yahoo! Finance]Yahoo! Finance
- ANI Pharma Insider Sells 4,772 Shares as Revenue Hits $883 Million in 2025 [Yahoo! Finance]Yahoo! Finance
- 3 Reasons ANIP is Risky and 1 Stock to Buy Instead [Yahoo! Finance]Yahoo! Finance
- ANI Pharmaceuticals Expands Ophthalmology Reach As Valuation Signals Upside Potential [Yahoo! Finance]Yahoo! Finance
- Sizing Up ANI Pharmaceuticals (ANIP) After Recent Share Price Pullback [Yahoo! Finance]Yahoo! Finance
ANIP
Earnings
- 2/27/26 - Beat
ANIP
Sec Filings
- 3/26/26 - Form SCHEDULE
- 3/13/26 - Form 4
- 3/13/26 - Form 4
- ANIP's page on the SEC website